课题基金 / 基金详情

Molecular analysis of aberrant signal transduction of membrane receptors as a basis for diagnosis and treatment of malignant lymphomas

Molecular analysis of aberrant signal transduction of membrane receptors as a basis for diagnosis and treatment of malignant lymphomas
膜受体异常信号转导的分子分析作为恶性淋巴瘤诊断和治疗的基础
批准号:
14370067
负责人:
WATANABE Toshiki
金额:
$8.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

WATANABE Toshiki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1)Hodgkin's lymphoma and anaplastic large cell lymphomas (ALCL) : We demonstrated that the constitutive activation of NF-kB results from "ligand-independent activation" of overexpressed CD30 on the Hodgkin/Reed-Sternberg (H-RS)cells, and that inhibition of CD30 signaling by transduction of a dominat negative decoy CD30 that lacks the cytoplasmic region induced apoptotic cell death of H-RS cells (Horie et al., Oncogene 21,2493,2002). We shoed that cytoplasmic aggregation of TRAF2 and TRAF5 proteins represents constant signaling of CD30 (Horie et al., Am J Pathol 160,1647,2002). We demonstrated that the AP-1 binding sequence located near the microsatellite counteracts the suppressive effects of the microsatellite on the CD30 promoter activity (Watanabe et al., Am J Pathol 163,633,2003). We showed that p80NPM-ALK inhibits ligand-independent signal transduction by overexpressed CD30 in ALCL cells though sequestration of TRAF proteins in the complex of NPM-ALK and wild type NPM (Horie et al., Cancer Cell 5,353,2004).(2)ATL :We demonstrated that GSK-3b-b-catenin-TCF/LEF pathway is a possible downstream target of the constitutively activated PKCbll in ATL cells.Expression profile analysis of ATL cells identified 67 genes as specifically overexpressed ones in ATL cells, 44 in activated T-cells of PBMC of HTLV-1 carriers, 24 in HTLV-1 infected cell lines.We revealed 5'-LTR specific CpG heavy methylation of HTLV-1 provirus in ATL cells and infected T-cells in peripheral blood of symptomatic carriers, which may be one base for latent infection of HTLV-1 (Koiwa et al., J Virol 76,9389,2002).
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s1535-6108(04)00084-4
发表时间: 2004-04-01
期刊: CANCER CELL
影响因子: 50.3
作者: [Horie, R, Watanabe, M, Watanabe, T]
通讯作者: Watanabe, T
AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
AP-1 介导解除霍奇金细胞和里德-斯滕伯格细胞中 CD30 启动子微卫星的抑制活性。
DOI: --
发表时间: 2003
期刊: Am J Pathol 163
影响因子: --
作者: [Watanabe M, Ogawa Y, Ito K, Higashihara M, Kadin ME, Abraham LJ, Watanabe T, Horie R]
通讯作者: Horie R
Ligand-independent signaling by overexpressed CD30 drivers NF-kB activation in Hodgkin-Reed Sternberg cells.
过表达 CD30 驱动霍奇金-里德·斯滕伯格细胞中 NF-kB 激活的配体独立信号传导。
DOI: --
发表时间: 2002
期刊: Oncogene 21
影响因子: --
作者: [Nabeshima T., Horie R]
通讯作者: Horie R
DOI: 10.1016/s0002-9440(10)61112-1
发表时间: 2002-05-01
期刊: AMERICAN JOURNAL OF PATHOLOGY
影响因子: 6
作者: [Horie, R, Watanabe, T, Watanabe, T]
通讯作者: Watanabe, T
19
    HTLV-1 hijacks T-cell differentiation/function by deregulatingHelios gene expression
    • 批准号:
      23659484
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      WATANABE Toshiki
    • 依托单位:
    Oncogene addiction of ATL cells and abnormal Polycomb-miRNA-signal transduction
    • 批准号:
      23390250
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      WATANABE Toshiki
    • 依托单位:
    Pursuit of a new system for a high throughput screening of drugs to develop a new strategy of prevention and treatment of ATL
    • 批准号:
      20390267
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2008
    • 负责人:
      WATANABE Toshiki
    • 依托单位:
    Abnormalities in TCR signal transduction in T cell non-Hodgkin's lymphoma as a basis for a new classification system.
    • 批准号:
      18390111
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.69万
    • 财政年份:
      2006
    • 负责人:
      WATANABE Toshiki
    • 依托单位:
    国内基金
    海外基金
    FOXM1/ISG15轴调控线粒体自噬维持ALK+ALCL干性导致化疗耐药的机制研究
    • 批准号:
      82300223
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      李静
    • 依托单位:
    铝-硫电池用AlCl3/乙酰胺电解液改性研究
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      64万元
    • 批准年份:
      2020
    • 负责人:
      尉海军
    • 依托单位:
    铝-硫电池用AlCl3/乙酰胺电解液改性研究
    • 批准号:
      22075007
    • 项目类别:
      面上项目
    • 资助金额:
      64.0万元
    • 批准年份:
      2020
    • 负责人:
      尉海军
    • 依托单位:
    新型固载化AlCl3催化剂上合成聚α-烯烃油(PAO)的研究
    • 批准号:
      20503004
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2005
    • 负责人:
      蒋山
    • 依托单位: